MADISON, Wis. AP – The University of Wisconsin-Madison’s patenting arm won an appeal Tuesday in federal court against Canadian drug company Xenon.

The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how Xenon handled patent rights to an enzyme that can lower cholesterol levels in the human body.